CoreWeave (CRWV) Form 144: 281,250 Founder Shares Proposed Sale $26.1M

CoreWeave, Inc. (CRWV) Form 144 filing discloses a proposed sale of 281,250 shares of Common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,125,312.50.

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 filing discloses a proposed sale of 281,250 shares of Common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,125,312.50. The shares were acquired as Founders Shares from the issuer on 12/27/2023 and payment was recorded on the same date. The filing lists 370,470,348 shares outstanding and indicates the approximate date of sale as 08/20/2025. No securities were reported sold in the prior three months, and the filer affirms they do not possess undisclosed material adverse information.

Positive

• Required disclosure provided under Rule 144 detailing broker, quantity, acquisition date, and aggregate market value
• Filer attests they do not possess undisclosed material adverse information, which is a regulatory safeguard

Negative

• Insider intends to sell founder shares, which could increase available float when executed
• Filing does not identify the selling person (name not provided in the excerpt), limiting investor ability to assess context

Insights

Securities Analyst

TL;DR: An insider filing to sell founder shares via Morgan Stanley for $26.1M on NASDAQ; routine disclosure, watch timing.

The filing documents a proposed sale of 281,250 common shares acquired as founders shares on 12/27/2023. The broker is Morgan Stanley Smith Barney LLC and the sale is slated for 08/20/2025. The filer affirms no undisclosed material adverse information. This is a standard Rule 144 notice enabling a restricted/controlled holder to publicly disclose an intended sale; it does not itself confirm execution or motive. For investors, the notice increases transparency about potential share supply but contains no new operational or financial performance data.

Corporate Governance Expert

TL;DR: Governance disclosure completed for proposed founder-share sale; signature attestations included, no compliance exceptions noted.

The form includes required attestations regarding material information and references Rule 10b5-1 considerations. It lists broker details and acquisition history (founders shares from issuer dated 12/27/2023). There are no reported securities sales in the past three months. The filing meets procedural requirements for controlled/insider dispositions under Rule 144 but does not provide identities or any trading plan text. From a governance perspective, the document fulfills notice obligations without revealing nonpublic operational matters.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRWV Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 281,250 common shares via Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $26,125,312.50 and an approximate sale date of 08/20/2025.

When were the shares being sold originally acquired according to the filing?

The shares were acquired as Founders Shares from the issuer on 12/27/2023, with payment recorded the same date.

Does the filing report any securities sold by the filer in the past three months?

No. The section 'Securities Sold During The Past 3 Months' states Nothing to Report.

Which broker and exchange are listed in the filing for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza and the listed exchange is NASDAQ.

What attestations does the filer make in the Form 144?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 plan considerations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/20/2025 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058067
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CoreWeave, Inc.
SEC File Number	001-42563
Address of Issuer	290 W Mt. Pleasant Ave. Livingston NEW JERSEY 07039
Phone	9732709737
Name of Person for Whose Account the Securities are To Be Sold	WEST CLAY CAPITAL LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	281250	26125312.50	370470348	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			281250	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brian Venturo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)